Insights

Innovation Focus Oncopeptides' dedicated pursuit of developing therapies for difficult-to-treat hematological diseases indicates potential demand for advanced pharmaceutical solutions, research tools, and specialized manufacturing technologies that support innovative drug development.

Emerging Market Presence With a modest revenue range and a focused U.S. footprint in major biotech hubs, Oncopeptides may be seeking scalable infrastructure, clinical trial support, and distribution partnerships to expand its market reach and accelerate product adoption.

Technology Adoption Utilization of cloud-based and web technologies such as Microsoft Azure, WordPress, and Shopify suggests openness to digital transformation, presenting opportunities for CRM, data analytics, and cybersecurity solutions tailored for biotech firms.

Partnership Opportunities Despite being smaller compared to giants like Johnson & Johnson or Pfizer, Oncopeptides' niche focus and innovation-driven approach make it a strategic partner for collaborations in clinical research, biotech innovations, and emerging treatment development.

Funding & Growth The company's ongoing financial development, coupled with its strong commitment to addressing unmet medical needs, suggests potential avenues for investment, joint ventures, and supply chain solutions to support rapid growth and product pipeline expansion.

Similar companies to Oncopeptides, Inc. (U.S.)

Oncopeptides, Inc. (U.S.) Tech Stack

Oncopeptides, Inc. (U.S.) uses 8 technology products and services including Cloudflare, WordPress, Shopify, and more. Explore Oncopeptides, Inc. (U.S.)'s tech stack below.

  • Cloudflare
    Content Management System
  • WordPress
    Content Management System
  • Shopify
    E-commerce
  • PWA
    Miscellaneous
  • Windows Server
    Operating Systems
  • Microsoft Azure
    Platform As A Service
  • HSTS
    Security
  • Google Tag Manager
    Tag Management

Media & News

Oncopeptides, Inc. (U.S.)'s Email Address Formats

Oncopeptides, Inc. (U.S.) uses at least 2 format(s):
Oncopeptides, Inc. (U.S.) Email FormatsExamplePercentage
First.Last@oncopeptides.comJohn.Doe@oncopeptides.com
91%
FirstLast@oncopeptides.comJohnDoe@oncopeptides.com
4%
First.Middle.Last@oncopeptides.comJohn.Michael.Doe@oncopeptides.com
3%
LastF@oncopeptides.comDoeJ@oncopeptides.com
2%
First-Last@oncopeptides-us.comJohn-Doe@oncopeptides-us.com
67%
LastF@oncopeptides-us.comDoeJ@oncopeptides-us.com
33%

Frequently Asked Questions

Where is Oncopeptides, Inc. (U.S.)'s headquarters located?

Minus sign iconPlus sign icon
Oncopeptides, Inc. (U.S.)'s main headquarters is located at 200 Fifth Avenue Suite #1030 Waltham, MA 02451 US. The company has employees across 1 continents, including North America.

What is Oncopeptides, Inc. (U.S.)'s official website and social media links?

Minus sign iconPlus sign icon
Oncopeptides, Inc. (U.S.)'s official website is oncopeptides-us.com and has social profiles on LinkedIn.

What is Oncopeptides, Inc. (U.S.)'s NAICS code?

Minus sign iconPlus sign icon
Oncopeptides, Inc. (U.S.)'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Oncopeptides, Inc. (U.S.) have currently?

Minus sign iconPlus sign icon
As of November 2021, Oncopeptides, Inc. (U.S.) has approximately 201 employees across 1 continents, including North America. Key team members include Head Of Research: F. L.Head Of Us Human Resources: M. F.Executive Director, Medical Affairs: E. M.. Explore Oncopeptides, Inc. (U.S.)'s employee directory with LeadIQ.

What industry does Oncopeptides, Inc. (U.S.) belong to?

Minus sign iconPlus sign icon
Oncopeptides, Inc. (U.S.) operates in the Pharmaceutical Manufacturing industry.

What technology does Oncopeptides, Inc. (U.S.) use?

Minus sign iconPlus sign icon
Oncopeptides, Inc. (U.S.)'s tech stack includes CloudflareWordPressShopifyPWAWindows ServerMicrosoft AzureHSTSGoogle Tag Manager.

What is Oncopeptides, Inc. (U.S.)'s email format?

Minus sign iconPlus sign icon
Oncopeptides, Inc. (U.S.)'s email format typically follows the pattern of First.Last@oncopeptides.com. Find more Oncopeptides, Inc. (U.S.) email formats with LeadIQ.

When was Oncopeptides, Inc. (U.S.) founded?

Minus sign iconPlus sign icon
Oncopeptides, Inc. (U.S.) was founded in 2000.

Oncopeptides, Inc. (U.S.)

Pharmaceutical ManufacturingMassachusetts, United States201-500 Employees

At Oncopeptides, we are committed to the development of therapies for difficult-to-treat hematological diseases.

We strive to bring hope to patients through science and innovation. Every day we are inspired by the perseverance that we see from patients, caregivers and health care providers in their fight against cancer. We are unwavering in our focus and dedication to bring forward new and meaningful treatment options.

Oncopeptides’ headquarters is in Stockholm, Sweden with a U.S. headquarters in Waltham, Massachusetts, outside of Boston. In addition to Waltham, Oncopeptides has a footprint in Los Altos, California, another U.S. biotechnology hub.

Section iconCompany Overview

Headquarters
200 Fifth Avenue Suite #1030 Waltham, MA 02451 US
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2000
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $1M$10M

    Oncopeptides, Inc. (U.S.)'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Oncopeptides, Inc. (U.S.)'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.